China YCT International Group, Inc. Announces That the State Intellectual Property Office of the People's Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutica... (t give us confidence that we can make su...)

HOME >> BIOLOGY >> TECHNOLOGY

China YCT International Group, Inc. Announces That the State Intellectual Property Office of the People's Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.

Date:1/25/2010

t, give us confidence that we can make successful inroads into China's healthcare market in the years ahead," said Mr. Tinghe Yan.

"Receiving this patent is another important milestone, as China YCT accelerates its strategic growth plan," said Mr. Yan. "We're committed to developing innovative products based on our experience in the gingko healthcare products industry. We intend this to be the first in a series of technological breakthroughs, and we will continue to seek legal protection for these innovations. The benefits of our new products enhance the value of the Company as a whole," Mr. Yan added.

About China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use chemical products, ginkgo glycoside products and biological medicines.

Safe Harbor Statement

The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets are examples of such forward-looking statement
'/>"/>

SOURCE China YCT International Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base
2. China Yongxin Pharmaceuticals Projects Higher Net Income and EPS on Reduced Revenue for Full-Year 2009
3. China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option
4. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
5. American Oriental Bioengineering Announces the Inclusion of 158 Drugs in Chinas National Insurance Catalog
6. China Sky Medical, Inc. Has 30 Medicines that will Be Included in Chinas National Insurance Directory
7. China Biologic Products to Ring NASDAQ Opening Bell
8. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
9. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
10. Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies
11. China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia

Post Your Comments:

(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...

(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...

(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...

(Date:5/21/2013)... Md. , May 21, 2013 MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM. The presentation ...

Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3 The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo [0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC [0] The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... 7, 2011 Reportlinker.com ... report is available in its catalogue: ... Shares, Strategies, and Forecasts, Worldwide, 2011 ... http://www.reportlinker.com/p0569001/Tele-Health-Monitoring-Market-Shares-Strategies-and-Forecasts-Worldwide-2011-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthcare WinterGreen Research ...

... is available in German . ... supplements. However, the production of this "functional food" has ... enough to survive conventional production processes. Researchers from Technische ... that allows the use of thus far unutilized probiotics. ...

... are among the oldest known life-forms, but they are ... that these single-celled microorganisms were designated as a domain ... eukaryotes. Robert Gunsalus, a UCLA professor ... in Archaea because of their ability to ...

Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 TUM researchers develop environmentally friendly process to improve storage stability of probiotics Old life capable of revealing new tricks after all

(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...

(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...

(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...

Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2 Insight into the dazzling impact of insulin in cells 2 Insight into the dazzling impact of insulin in cells 3 Gym class reduces probability of obesity, study finds for first time 2

[0] Do men's and women's hearts burn fuel differently?[0] Insight into the dazzling impact of insulin in cells [0] Gym class reduces probability of obesity, study finds for first time

... A study published in this week,s online issue of ... sensitive method for detecting methylation-associated cancers. ... of methyl groups has been established as a common ... levels of DNA methylation, which effectively disrupt the genes ...

... research shows that air pollution in eastern China has reduced ... and decreased by 23 percent the number of days of ... results suggest that bad air quality might be affecting the ... health and environmental problems. The study links for the ...

... Dresden research team used laser tweezers to measure the ... track. The team found that also within our ... are restrained in its operationusually by far not as ... experimental measurements of protein friction could help researchers to ...

Cached Biology News:Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 2 Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 2 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 4 Bionanomachines -- proteins as resistance fighters 2

Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer The sky is not falling: Pollution in eastern China cuts light, useful rainfall Bionanomachines -- proteins as resistance fighters

Request Info...

Applications: (+) Immunocytochemistry and immunohistochemistry...

RABBIT ANTI WARFARIN...

Request Info...

Biology Products:

Rat IFN-gamma ELISpot Development Kit from R&D Systems Normal Goat Serum from Cayman Chemical Rabbit Anti-WARFARIN Polyclonal Antibody, Unconjugated from AbD Serotec MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems